AKT1 and hepatocellular carcinoma: HCC has recently been stratified into three subtypes differing in metabolic and signaling pathways, including altered kynurenine metabolism, Wnt/β-catenin-associated lipid metabolism, and PI3K/AKT/mTOR signaling [11].